Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2016 by Stanford University
Sponsor:
Collaborators:
The Leukemia and Lymphoma Society
Biospect Inc
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT00398177
First received: November 9, 2006
Last updated: April 12, 2016
Last verified: April 2016
  Purpose
The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.

Condition
Lymphoma, Non-Hodgkin
Hodgkin's Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

Resource links provided by NLM:


Further study details as provided by Stanford University:

Primary Outcome Measures:
  • Collection of tumor tissue to characterize the molecular and cell biology of tumor cells in lymphoma. [ Time Frame: The study will continue indefinitely. ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples Without DNA
tumor tissue

Estimated Enrollment: 9999
Study Start Date: June 1999
Estimated Study Completion Date: June 2017
Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)
Detailed Description:
This research involves the study of lymphoma cells in order to better understand how the disease grows and spreads. This study may lead to the development of special materials that could be used, in the future, to treat lymphoma or to follow the response of lymphoma to treatment.
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Any type of NHL or Hodgkin's disease.
Criteria

Inclusion Criteria:

  • Diagnosis of Hodgkin's disease or non-Hodgkin's lymphoma, any cellular classification, any stage, any grade.
  • Adult or pediatric patients receiving lymph node excision for purposes other than cancer therapy (i.e. tonsillectomy, sleep apnea).
  • A routine procedure for tissue collection is planned.
  • Ability to understand and the willingness to sign a written informed consent.

Exclusion Criteria:

  • Patients without NHL or Hodgkin's disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00398177

Locations
United States, California
Stanford University School of Medicine Recruiting
Stanford, California, United States, 94305
Contact: Cancer Clinical Trials Office    650-498-7061    ccto-office@stanford.edu   
Principal Investigator: Ronald Levy         
Sub-Investigator: Gideon Gross         
Sub-Investigator: Shoshana Levy         
Sponsors and Collaborators
Stanford University
The Leukemia and Lymphoma Society
Biospect Inc
Investigators
Principal Investigator: Ronald Levy, MD Stanford University
  More Information

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT00398177     History of Changes
Other Study ID Numbers: LYM0001  76973  LYM0001  IRB-13500 
Study First Received: November 9, 2006
Last Updated: April 12, 2016
Health Authority: United States: Food and Drug Administration
United States: Institutional Review Board
United States: Data and Safety Monitoring Board

Additional relevant MeSH terms:
Lymphoma
Lymphoma, Non-Hodgkin
Hodgkin Disease
Neoplasms by Histologic Type
Neoplasms
Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases

ClinicalTrials.gov processed this record on July 28, 2016